Izalontamab Brengitecan

Approval Year

Substance Class	Protein Created by `admin` on `Wed Apr 02 17:09:39 GMT 2025` Edited by `admin` on `Wed Apr 02 17:09:39 GMT 2025`
Protein Type	BISPECIFIC ANTIBODY
Protein Sub Type	IGG1
Sequence Origin	HUMANIZED MOUSE
Sequence Type	COMPLETE
Record UNII	UC2FX6YY3P
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

Immunoglobulin G1 [de-448-lysine], anti-(human epidermal growth factor receptor) (human-mouse monoclonal C225 ?1-chain) fusion protein with peptide linker (GGGGS)2 fusion protein with immunoglobulin anti-(human epidermal growth factor receptor HER3) (hum

Preferred Name

English

Izalontamab Brengitecan

Official Name

English

BL-B01D1

Code

English

Immunoglobulin G1-scFv_L-kappa dimer, anti-[Homo sapiens EGFR (epidermal growth factor receptor, receptor tyrosine-protein kinase erbB-1, ERBB1, HER1, HER-1, ERBB)] and anti-[Homo sapiens ERBB3 (receptor tyrosine protein kinase erbB-3, HER3)], chimeric a

Common Name

English

IZALONTAMAB BRENGITECAN [USAN]

Common Name

English

BMS-986507

Code

English

BMS986507

Code

English

izalontamab brengitecan [INN]

Common Name

English

Fused G1-scFv heavy-lambda heavy chain chimeric and Homo sapiens (1-702) [gamma1 heavy chain anti-EGFR chimeric (1-448) [VH (Mus musculus IGHV2-2*03 (93.8%) -(IGHD) -IGHJ3*01 (92.9%) A128>S (119), CDR-IMGT [8.7.13] (26-33.51-57.96-108)) (1-119) -Homo sap

Common Name

English

Code System Code Type Description

INN

12678